Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
摘要：
PURPOSE: Breast cancer frequently overexpresses the product of the HER2 proto-oncogene, a 185-kd growth factor receptor (p185HER2). The recombinant humanized monoclonal antibody (rhuMAb) HER2 has high affinity for p185HER2 and inhibits the growth of breast cancer cells that overexpress HER2. We evaluated the efficacy and toxicity of weekly intravenous administration of rhuMAb HER2 in patients with HER2-overexpressing metastatic breast cancer. PATIENTS AND METHODS: We treated 46 patients with metastatic breast carcinomas that overexpressed HER2. Patients received a loading dose of 250 mg of intravenous rhuMAb HER2, then 10 weekly doses of 100 mg each. Patients with no disease progression at the completion of this treatment period were offered a maintenance phase of 100 mg/wk. RESULTS: Study patients had extensive metastatic disease, and most had received extensive prior anticancer therapy. Adequate pharmacokinetic levels of rhuMAb HER2 were obtained in 90% of the patients. Toxicity was minimal and no antibodies against rhuMAb HER2 were detected in any patients. Objective responses were seen in five of 43 assessable patients, and included one complete remission and four partial remissions (overall response rate, 11.6%; 95% confidence interval, 4.36 to 25.9). Responses were observed in liver, mediastinum, lymph nodes, and chest wall lesions. Minor responses, seen in two patients, and stable disease, which occurred in 14 patients, lasted for a median of 5.1 months. CONCLUSION: rhuMAb HER2 is well tolerated and clinically active in patients with HER2-overexpressing metastatic breast cancers that had received extensive prior therapy. This is evidence that targeting growth factor receptors can cause regression of human cancer and justifies further evaluation of this agent.
展开
DOI：
10.1200/JCO.1996.14.3.737
被引量：
年份：
1996
Taylor & Francis
万方医学
掌桥科研
dx.doi.org
NCBI
查看更多
Oxford Univ Press
JBC
ResearchGate
EBSCO
onAcademic
mendeley.com
nejm.org
theoncologist.alphamedpress.org
mdanderson.influuent.utsystem.edu
erc.endocrinology-journals.org
jimmunol.org
www.socolar.com
annclinlabsci.org
ar.iiarjournals.org
emboj.embopress.org
fasebj.org
jpet.aspetjournals.org
mysciencework.com
mp.bmjjournals.com
scienceopen.com
cghjournal.org
mayoclinicproceedings.org
clinchem.org
mct.aacrjournals.org
nucmedbio.com
mcb.asm.org
clinical-lung-cancer.com
jco.ascopubs.org
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
